These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7910707)

  • 1. [Ulcer surgery and anti-ulcer agents. Changes in surgical activities and sale of anti-ulcer agents in Nord-Trøndelag 1975-89].
    Haaverstad R; Moen OO; Kannelønning KS; Line PD; Wibe A; Bjerkeset T
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):904-7. PubMed ID: 7910707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in ulcer surgery following introduction of H2-blockers].
    Paimela H; Kivilaakso E; Tuompo P; Peräkylä T; Höckerstedt K; Saarlo I
    Nord Med; 1991; 106(6-7):198-201. PubMed ID: 1677178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of surgery in the therapy of peptic ulcer after arrival of H2-blocking drugs].
    Perri S; Amendolara M; Breda E; Todarello V; Gallo G; Pietrangeli F; Meneghini G; Gelmi GF
    G Chir; 1990 Sep; 11(9):466-70. PubMed ID: 1981139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Choice of the method of treatment of uncomplicated gastric and duodenal ulcers].
    Petrov VP
    Khirurgiia (Mosk); 2001; (7):13-6. PubMed ID: 11521301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti H2 receptors and perforated peptic ulcer. Review of 442 cases].
    Mastroianni V; Calgaro M; Manfredi S; Manzini R; Bevilacqua S
    Minerva Chir; 1989 Nov; 44(21):2259-62. PubMed ID: 2576300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment of ulcer disease 5 years before and after the introduction of cimetidine].
    Rohner HG; Blömer A; Echterhoff HM; Gugler R
    Z Gastroenterol; 1983 Oct; 21(10):585-92. PubMed ID: 6649737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].
    Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V
    Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration].
    Bonardelli P; Fujita Y; Fujita R; Sugata F
    Clin Ter; 1987 Aug; 122(3):183-7. PubMed ID: 2904317
    [No Abstract]   [Full Text] [Related]  

  • 9. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of anti-H2-receptors on the surgery of peptic ulcer].
    Cavallesco NG; Morsiani E; Lupi L; Dalla Valle GB; Fogli L; Belcastro S; Pampolini M; Pollice S; Santini A
    Minerva Chir; 1987 Oct; 42(19):1495-7. PubMed ID: 2891086
    [No Abstract]   [Full Text] [Related]  

  • 11. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
    Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
    Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice].
    Rimassa PL; Marino G; Quartapelle V; D'Asta F; Maggiolo G; Manno A; Piffero D; Schiappacasse E
    Minerva Chir; 1987 Oct; 42(19):1499-502. PubMed ID: 2891087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents].
    Bartolotta M; Carditello A
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trend in emergency surgery for perforated duodenal ulcer.
    Gürleyik E
    J Coll Physicians Surg Pak; 2003 Dec; 13(12):708-10. PubMed ID: 15569558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ulcer surgery during 1976-1978 and 1986-1988. Significance of H2 blockaders in surgical training].
    Meisner S; Sørensen A; Wille-Jørgensen PA
    Ugeskr Laeger; 1993 Nov; 155(47):3828-32. PubMed ID: 7903009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the need for operation for peptic pyloric stenosis over a period of 24 years (1976-1999).
    Piñero Madrona A; Robles R; López J; Montoya M; Aguayo JL; Sánchez-Bueno F; Parrilla P
    Eur J Surg; 2001 Oct; 167(10):758-60. PubMed ID: 11775727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgical treatment of gastroduodenal ulcer disease. Our experience after the advent of H2-antagonist drugs].
    Carrella G; Salomoni C; De Anna D; Pozza E; Sortini A; Guerrera C; Pansini GC; Marcello D; Vettorello GF
    Minerva Chir; 1987 Oct; 42(19):1483-5. PubMed ID: 2891084
    [No Abstract]   [Full Text] [Related]  

  • 20. [The surgical treatment of patients with perforated stomach and duodenal ulcers].
    Kurygin AA; Peregudov SI; Gulua FI
    Vestn Khir Im I I Grek; 1998; 157(4):24-7. PubMed ID: 9825432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.